Simple blood test could lead to personalized lung cancer treatment
medicalxpress - A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of t…
AI Summary: Researchers describe a circulating cell-free methylated DNA liquid biopsy that can detect and track lung cancer by reading tumor-specific methylation patterns in blood. The minimally invasive test aims to guide personalized treatment choices, enable earlier detection of recurrence, and reduce dependence on tissue biopsies—basically doing the diagnostic heavy lifting while you sip your coffee.
- Blood tests for monitoring and personalizing lung cancer care (4)
- MCED trials and clinical benefit debate (4)
- Methylation liquid biopsy methods and applications (4)
- All Other Stories
Blood tests for monitoring and personalizing lung cancer care
MCED trials and clinical benefit debate
Methylation liquid biopsy methods and applications
All Other Stories
Related Stories
National study to use genetic testing to guide cancer survivor follow-up / 3 months
Air pollution causes detectable blood changes years before lung cancer / 15 days
Repeat PSMA PET scans change prostate cancer care for many patients / 6 wks
ctDNA blood test pinpoints who needs chemo after colorectal liver surgery / 7 wks
Early‑onset cancers rising; family history crucial for prevention / 2 months
Ultrasensitive HPV blood test detects head and neck recurrence months earlier / 2 months
Prosigna-guided OPTIMA trial shows chemo can be safely skipped in many ER+/HER2− breast cancers / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Biotech, Drug Development, Pharmaceuticals, Medicare Advantage (not listed) and look for the RSS link.
StackHealth Time Machine